Dermatofibroma medical therapy: Difference between revisions
Jump to navigation
Jump to search
m (Bot: Removing from Primary care) |
|||
| Line 15: | Line 15: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
| |||
[[Category:Medicine]] | [[Category:Medicine]] | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Up-To-Date | [[Category:Up-To-Date]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
Latest revision as of 21:18, 29 July 2020
|
Dermatofibroma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Dermatofibroma medical therapy On the Web |
|
American Roentgen Ray Society Images of Dermatofibroma medical therapy |
|
Risk calculators and risk factors for Dermatofibroma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]
Overview
There is no pharmacologic medical therapy for dermatofibromas . Dermatofibromas are benign and no treatment is generally needed. If the treatment is needed, local excision is the mainstay one.
Medical Therapy
- Dermatofibromas are benign and no treatment is generally needed.
References
- ↑ Jakobiec, Frederick A.; Tu, Yufei; Zakka, Fouad R.; Tong, Arthur K.F. (2017). "Dermatofibroma of the eyelid with monster cells". Survey of Ophthalmology. 62 (4): 533–540. doi:10.1016/j.survophthal.2016.12.007. ISSN 0039-6257.